AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "cg1111-screening-for-downs-edwards-and-pataus-syndrome-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 1330
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "NIPT Screening for Down’s, Edward’s, and Patau’s Syndromes",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "NICE",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "The text provided does not contain a publication year. If you have another guideline text that includes the year, please share it, and I can extract the 4-digit year for you",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary of Screening for Down’s, Edward’s, and Patau’s Syndrome Guideline:** - **Screening Offer**: NIPT (non-invasive prenatal testing) for T21, T18, and T13 is offered after a higher-chance result from combined or quadruple tests. - **Options**: Women may choose no further testing, NIPT, or prenatal diagnosis. Results are reported as lower or higher chance. - **Timing**: Testing available up to 21+6 weeks, with results expected within 2 weeks. Samples may be retained for quality assurance. - **Eligibility**: Includes IVF and donor egg pregnancies. - **Follow-up**: Clear referral pathways for abnormal results. - **Staff Requirements**: Midwives must meet education/training standards. - **Audit**: Monitoring processes ensure guideline adherence. **Purpose**: Supports informed decision-making, timely results, and optimal care for confirmed diagnoses. Applies to all involved staff",
      "action": "added"
    }
  ]
}